List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 45 studies with search of: bladder cancer AND new jersey
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Terminated Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
Condition: Bladder Cancer
Interventions: Biological: recombinant fowlpox GM-CSF vaccine adjuvant;   Biological: recombinant fowlpox-TRICOM vaccine;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
2 Active, not recruiting Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Condition: Cancer
Intervention: Biological: therapeutic allogeneic lymphocytes
3 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer;   Prostate Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Biological: bevacizumab;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: placebo administration
4 Completed Combination Chemotherapy in Treating Patients With Bladder Cancer
Conditions: Bladder Cancer;   Urethral Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: methotrexate;   Drug: paclitaxel;   Drug: vinblastine sulfate
5 Unknown † Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
6 Terminated Combination Chemotherapy in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride
7 Completed Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Drug: docetaxel;   Drug: gemcitabine hydrochloride
8 Recruiting Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Conditions: Bladder Neoplasm;   Intravesical Drug Administration;   Neoplasm Recurrence, Local;   Transitional Cell, Carcinoma;   Carcinoma in Situ;   Mycobacterium
Intervention: Biological: EN3348
9 Active, not recruiting Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing TUR-BT
Condition: Bladder Cancer
Intervention: Drug: EOquin®
10 Completed
Has Results 		A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Bladder Cancer;   Urethra Cancer;   Ureter Cancer;   Renal Pelvis Cancer
Intervention: Drug: AZD4877
11 Active, not recruiting A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
Conditions: Bladder Cancer;   CIS
Intervention:
12 Active, not recruiting Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: EOquin® (Apaziquone)
13 Completed Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
Condition: Bladder Cancer Recurrence
Intervention:
14 Completed Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Conditions: Bladder Cancer;   Renal Pelvis and Ureter Urothelial Carcinoma;   Urethral Cancer
Interventions: Drug: cisplatin;   Drug: Iressa;   Drug: gemcitabine hydrochloride
15 Completed Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium
16 Completed Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Intervention: Drug: piritrexim
17 Recruiting Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Condition: Cancer
Interventions: Drug: hydroxychloroquine;   Drug: sunitinib malate
18 Completed
Has Results 		Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
Conditions: Bladder Cancer;   Urothelial Cancer
Intervention: Drug: sorafenib
19 Completed Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Intervention: Drug: bortezomib
20 Active, not recruiting Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Conditions: Bladder Cancer;   Urinary Bladder
Intervention: Drug: Gemcitabine, Cisplatin, and Sunitinib

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services